0001950047-24-004319.txt : 20240603 0001950047-24-004319.hdr.sgml : 20240603 20240603163807 ACCESSION NUMBER: 0001950047-24-004319 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vor Biopharma Inc. CENTRAL INDEX KEY: 0001817229 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39979 FILM NUMBER: 241014278 BUSINESS ADDRESS: STREET 1: 100 CAMBRIDGEPARK DRIVE STREET 2: SUITE 101 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-655-6580 MAIL ADDRESS: STREET 1: 100 CAMBRIDGEPARK DRIVE STREET 2: SUITE 101 CITY: CAMBRIDGE STATE: MA ZIP: 02140 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Attar Eyal C. CENTRAL INDEX KEY: 0001789076 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Attar Eyal DATE OF NAME CHANGE: 20190923 144 1 primary_doc.xml 144 0001789076 XXXXXXXX LIVE 0001817229 VOR BIOPHARMA INC 001-39979 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140 6176556580 EYAL ATTAR Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

14645 19770.75 68259602 06/03/2024 NASDAQ Common 05/06/2023 Restricted Stock Units Issuer N 14645 05/06/2023 N/A Y The securities to be sold were acquired upon the vesting of restricted stock units during the period of 05/06/2023 through 05/06/2024. 06/03/2024 03/04/2024 /s/ Eyal Attar